ALLISON BALL: Open Payments
NPI 1932606043 · FORT VALLEY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 21 payments from 10 companies in 2025. Trend: 2023 $191 · 2024 $423 · 2025 $418
Food & beverage: $414Education: $3
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Travere Therapeutics, Inc. | 6 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| Fresenius USA Manufacturing, Inc. | 1 | $23 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
Products named: JYNARQUE, Kerendia, FARXIGA, JARDIANCE, Wegovy, TARPEYO, VELPHORO, LUPKYNIS.
Industry payments across GA — which companies pay providers there.
